nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—Cytochrome P450 2D6 Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.71	1	CiPCiCtD
Desvenlafaxine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0223	0.126	CbGbCtD
Desvenlafaxine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0209	0.119	CbGbCtD
Desvenlafaxine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0209	0.119	CbGbCtD
Desvenlafaxine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0189	0.107	CbGbCtD
Desvenlafaxine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0189	0.107	CbGbCtD
Desvenlafaxine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0163	0.0925	CbGbCtD
Desvenlafaxine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0159	0.0898	CbGbCtD
Desvenlafaxine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0143	0.0812	CbGbCtD
Desvenlafaxine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0143	0.0812	CbGbCtD
Desvenlafaxine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0137	0.0779	CbGbCtD
Desvenlafaxine—SLC6A2—nerve—acquired immunodeficiency syndrome	0.000735	0.173	CbGeAlD
Desvenlafaxine—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.000632	0.149	CbGeAlD
Desvenlafaxine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000309	0.0728	CbGeAlD
Desvenlafaxine—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000243	0.0571	CbGeAlD
Desvenlafaxine—SLC6A4—blood—acquired immunodeficiency syndrome	0.000231	0.0544	CbGeAlD
Desvenlafaxine—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000223	0.0524	CbGeAlD
Desvenlafaxine—SLC6A4—lung—acquired immunodeficiency syndrome	0.000203	0.0477	CbGeAlD
Desvenlafaxine—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000188	0.0442	CbGeAlD
Desvenlafaxine—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000181	0.0425	CbGeAlD
Desvenlafaxine—SLC6A2—lung—acquired immunodeficiency syndrome	0.000179	0.042	CbGeAlD
Desvenlafaxine—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000165	0.0389	CbGeAlD
Desvenlafaxine—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000159	0.0374	CbGeAlD
Desvenlafaxine—SLC6A4—brain—acquired immunodeficiency syndrome	0.000144	0.0338	CbGeAlD
Desvenlafaxine—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.00129	CcSEcCtD
Desvenlafaxine—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.00129	CcSEcCtD
Desvenlafaxine—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.00128	CcSEcCtD
Desvenlafaxine—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.00128	CcSEcCtD
Desvenlafaxine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00014	0.00128	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.00128	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.00128	CcSEcCtD
Desvenlafaxine—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.00014	0.00128	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.00128	CcSEcCtD
Desvenlafaxine—Chills—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.00128	CcSEcCtD
Desvenlafaxine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.00127	CcSEcCtD
Desvenlafaxine—Tension—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.00126	CcSEcCtD
Desvenlafaxine—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.00126	CcSEcCtD
Desvenlafaxine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.00126	CcSEcCtD
Desvenlafaxine—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.00126	CcSEcCtD
Desvenlafaxine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.00126	CcSEcCtD
Desvenlafaxine—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.00125	CcSEcCtD
Desvenlafaxine—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.00125	CcSEcCtD
Desvenlafaxine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000136	0.00125	CcSEcCtD
Desvenlafaxine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.00125	CcSEcCtD
Desvenlafaxine—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.00125	CcSEcCtD
Desvenlafaxine—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.00124	CcSEcCtD
Desvenlafaxine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000135	0.00124	CcSEcCtD
Desvenlafaxine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000135	0.00124	CcSEcCtD
Desvenlafaxine—Shock—Indinavir—acquired immunodeficiency syndrome	0.000135	0.00124	CcSEcCtD
Desvenlafaxine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.00123	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000134	0.00123	CcSEcCtD
Desvenlafaxine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000134	0.00123	CcSEcCtD
Desvenlafaxine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.00123	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.00123	CcSEcCtD
Desvenlafaxine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.00123	CcSEcCtD
Desvenlafaxine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000133	0.00122	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.00122	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.00122	CcSEcCtD
Desvenlafaxine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.00122	CcSEcCtD
Desvenlafaxine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000133	0.00122	CcSEcCtD
Desvenlafaxine—Chills—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.00122	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000132	0.00121	CcSEcCtD
Desvenlafaxine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000132	0.00121	CcSEcCtD
Desvenlafaxine—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.00121	CcSEcCtD
Desvenlafaxine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.00121	CcSEcCtD
Desvenlafaxine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.00121	CcSEcCtD
Desvenlafaxine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.00121	CcSEcCtD
Desvenlafaxine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.0012	CcSEcCtD
Desvenlafaxine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000131	0.0012	CcSEcCtD
Desvenlafaxine—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.0012	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000129	0.00119	CcSEcCtD
Desvenlafaxine—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.00118	CcSEcCtD
Desvenlafaxine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.00118	CcSEcCtD
Desvenlafaxine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000128	0.00117	CcSEcCtD
Desvenlafaxine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.00117	CcSEcCtD
Desvenlafaxine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000127	0.00117	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.00117	CcSEcCtD
Desvenlafaxine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.00116	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.00116	CcSEcCtD
Desvenlafaxine—SLC6A2—brain—acquired immunodeficiency syndrome	0.000126	0.0297	CbGeAlD
Desvenlafaxine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.00116	CcSEcCtD
Desvenlafaxine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.00116	CcSEcCtD
Desvenlafaxine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.00116	CcSEcCtD
Desvenlafaxine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.00116	CcSEcCtD
Desvenlafaxine—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.00116	CcSEcCtD
Desvenlafaxine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.00116	CcSEcCtD
Desvenlafaxine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000126	0.00115	CcSEcCtD
Desvenlafaxine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000126	0.00115	CcSEcCtD
Desvenlafaxine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.00115	CcSEcCtD
Desvenlafaxine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.00115	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000125	0.00115	CcSEcCtD
Desvenlafaxine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.00115	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.00115	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000125	0.00114	CcSEcCtD
Desvenlafaxine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000124	0.00114	CcSEcCtD
Desvenlafaxine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.00114	CcSEcCtD
Desvenlafaxine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000124	0.00114	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.00113	CcSEcCtD
Desvenlafaxine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000123	0.00113	CcSEcCtD
Desvenlafaxine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000123	0.00113	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000123	0.00113	CcSEcCtD
Desvenlafaxine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000123	0.00113	CcSEcCtD
Desvenlafaxine—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000122	0.0287	CbGeAlD
Desvenlafaxine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000122	0.00112	CcSEcCtD
Desvenlafaxine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000122	0.00112	CcSEcCtD
Desvenlafaxine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.00112	CcSEcCtD
Desvenlafaxine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000122	0.00112	CcSEcCtD
Desvenlafaxine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000121	0.00111	CcSEcCtD
Desvenlafaxine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.00111	CcSEcCtD
Desvenlafaxine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.00111	CcSEcCtD
Desvenlafaxine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.00111	CcSEcCtD
Desvenlafaxine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.00111	CcSEcCtD
Desvenlafaxine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.00111	CcSEcCtD
Desvenlafaxine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.00111	CcSEcCtD
Desvenlafaxine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.0011	CcSEcCtD
Desvenlafaxine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00012	0.0011	CcSEcCtD
Desvenlafaxine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00012	0.0011	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.0011	CcSEcCtD
Desvenlafaxine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000119	0.028	CbGeAlD
Desvenlafaxine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000119	0.00109	CcSEcCtD
Desvenlafaxine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.00109	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.00109	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.00109	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000118	0.00108	CcSEcCtD
Desvenlafaxine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000118	0.00108	CcSEcCtD
Desvenlafaxine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.00108	CcSEcCtD
Desvenlafaxine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000117	0.00107	CcSEcCtD
Desvenlafaxine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.00107	CcSEcCtD
Desvenlafaxine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.00107	CcSEcCtD
Desvenlafaxine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.00107	CcSEcCtD
Desvenlafaxine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.00107	CcSEcCtD
Desvenlafaxine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000116	0.00107	CcSEcCtD
Desvenlafaxine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.00107	CcSEcCtD
Desvenlafaxine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000116	0.00106	CcSEcCtD
Desvenlafaxine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000116	0.00106	CcSEcCtD
Desvenlafaxine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.00106	CcSEcCtD
Desvenlafaxine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.00106	CcSEcCtD
Desvenlafaxine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.00105	CcSEcCtD
Desvenlafaxine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.00105	CcSEcCtD
Desvenlafaxine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000114	0.00105	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.00105	CcSEcCtD
Desvenlafaxine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000113	0.0267	CbGeAlD
Desvenlafaxine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.00104	CcSEcCtD
Desvenlafaxine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.00103	CcSEcCtD
Desvenlafaxine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.00103	CcSEcCtD
Desvenlafaxine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.00103	CcSEcCtD
Desvenlafaxine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000112	0.00103	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.00103	CcSEcCtD
Desvenlafaxine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000112	0.00103	CcSEcCtD
Desvenlafaxine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.00103	CcSEcCtD
Desvenlafaxine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.00102	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.00102	CcSEcCtD
Desvenlafaxine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.00102	CcSEcCtD
Desvenlafaxine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000111	0.00102	CcSEcCtD
Desvenlafaxine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.00102	CcSEcCtD
Desvenlafaxine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.00102	CcSEcCtD
Desvenlafaxine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.00102	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.00101	CcSEcCtD
Desvenlafaxine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.00101	CcSEcCtD
Desvenlafaxine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00011	0.00101	CcSEcCtD
Desvenlafaxine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00011	0.00101	CcSEcCtD
Desvenlafaxine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00011	0.00101	CcSEcCtD
Desvenlafaxine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.00101	CcSEcCtD
Desvenlafaxine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00011	0.00101	CcSEcCtD
Desvenlafaxine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.001	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000998	CcSEcCtD
Desvenlafaxine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000994	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000991	CcSEcCtD
Desvenlafaxine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000108	0.000991	CcSEcCtD
Desvenlafaxine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000108	0.000988	CcSEcCtD
Desvenlafaxine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000987	CcSEcCtD
Desvenlafaxine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000983	CcSEcCtD
Desvenlafaxine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000107	0.000982	CcSEcCtD
Desvenlafaxine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000107	0.000982	CcSEcCtD
Desvenlafaxine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000981	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.00098	CcSEcCtD
Desvenlafaxine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000107	0.000979	CcSEcCtD
Desvenlafaxine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000979	CcSEcCtD
Desvenlafaxine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000107	0.000979	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000977	CcSEcCtD
Desvenlafaxine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000106	0.000976	CcSEcCtD
Desvenlafaxine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000106	0.000973	CcSEcCtD
Desvenlafaxine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000106	0.000973	CcSEcCtD
Desvenlafaxine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000971	CcSEcCtD
Desvenlafaxine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000105	0.000969	CcSEcCtD
Desvenlafaxine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000105	0.000965	CcSEcCtD
Desvenlafaxine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000105	0.000964	CcSEcCtD
Desvenlafaxine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000104	0.000959	CcSEcCtD
Desvenlafaxine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000104	0.000956	CcSEcCtD
Desvenlafaxine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000949	CcSEcCtD
Desvenlafaxine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000948	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000945	CcSEcCtD
Desvenlafaxine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000943	CcSEcCtD
Desvenlafaxine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000936	CcSEcCtD
Desvenlafaxine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000933	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000932	CcSEcCtD
Desvenlafaxine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000101	0.000926	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000925	CcSEcCtD
Desvenlafaxine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000101	0.000924	CcSEcCtD
Desvenlafaxine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.0001	0.000923	CcSEcCtD
Desvenlafaxine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	9.95e-05	0.000914	CcSEcCtD
Desvenlafaxine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	9.94e-05	0.000912	CcSEcCtD
Desvenlafaxine—Nausea—Abacavir—acquired immunodeficiency syndrome	9.9e-05	0.000909	CcSEcCtD
Desvenlafaxine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	9.88e-05	0.000907	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	9.87e-05	0.000906	CcSEcCtD
Desvenlafaxine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	9.86e-05	0.000905	CcSEcCtD
Desvenlafaxine—Asthenia—Indinavir—acquired immunodeficiency syndrome	9.81e-05	0.000901	CcSEcCtD
Desvenlafaxine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	9.78e-05	0.000898	CcSEcCtD
Desvenlafaxine—Constipation—Ritonavir—acquired immunodeficiency syndrome	9.78e-05	0.000898	CcSEcCtD
Desvenlafaxine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	9.72e-05	0.000893	CcSEcCtD
Desvenlafaxine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	9.56e-05	0.000878	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	9.52e-05	0.000874	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	9.5e-05	0.000872	CcSEcCtD
Desvenlafaxine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	9.49e-05	0.000872	CcSEcCtD
Desvenlafaxine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	9.49e-05	0.000871	CcSEcCtD
Desvenlafaxine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	9.42e-05	0.000865	CcSEcCtD
Desvenlafaxine—Constipation—Saquinavir—acquired immunodeficiency syndrome	9.41e-05	0.000864	CcSEcCtD
Desvenlafaxine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	9.36e-05	0.000859	CcSEcCtD
Desvenlafaxine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	9.35e-05	0.000858	CcSEcCtD
Desvenlafaxine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	9.33e-05	0.000857	CcSEcCtD
Desvenlafaxine—Rash—Zidovudine—acquired immunodeficiency syndrome	9.27e-05	0.000851	CcSEcCtD
Desvenlafaxine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	9.27e-05	0.000851	CcSEcCtD
Desvenlafaxine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	9.26e-05	0.000851	CcSEcCtD
Desvenlafaxine—Headache—Zidovudine—acquired immunodeficiency syndrome	9.21e-05	0.000846	CcSEcCtD
Desvenlafaxine—CYP3A4—nervous system—acquired immunodeficiency syndrome	9.2e-05	0.0216	CbGeAlD
Desvenlafaxine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	9.12e-05	0.000838	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	9.11e-05	0.000836	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	9.06e-05	0.000832	CcSEcCtD
Desvenlafaxine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	9.05e-05	0.000831	CcSEcCtD
Desvenlafaxine—Dizziness—Indinavir—acquired immunodeficiency syndrome	9.04e-05	0.00083	CcSEcCtD
Desvenlafaxine—Constipation—Lamivudine—acquired immunodeficiency syndrome	8.98e-05	0.000824	CcSEcCtD
Desvenlafaxine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	8.87e-05	0.000814	CcSEcCtD
Desvenlafaxine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	8.86e-05	0.0208	CbGeAlD
Desvenlafaxine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	8.84e-05	0.000812	CcSEcCtD
Desvenlafaxine—Nausea—Zidovudine—acquired immunodeficiency syndrome	8.73e-05	0.000802	CcSEcCtD
Desvenlafaxine—Vomiting—Indinavir—acquired immunodeficiency syndrome	8.69e-05	0.000798	CcSEcCtD
Desvenlafaxine—Rash—Indinavir—acquired immunodeficiency syndrome	8.62e-05	0.000792	CcSEcCtD
Desvenlafaxine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	8.61e-05	0.000791	CcSEcCtD
Desvenlafaxine—Headache—Indinavir—acquired immunodeficiency syndrome	8.57e-05	0.000787	CcSEcCtD
Desvenlafaxine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	8.54e-05	0.000785	CcSEcCtD
Desvenlafaxine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	8.46e-05	0.000777	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	8.42e-05	0.000773	CcSEcCtD
Desvenlafaxine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	8.21e-05	0.000754	CcSEcCtD
Desvenlafaxine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	8.2e-05	0.000753	CcSEcCtD
Desvenlafaxine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	8.17e-05	0.000751	CcSEcCtD
Desvenlafaxine—Rash—Efavirenz—acquired immunodeficiency syndrome	8.15e-05	0.000748	CcSEcCtD
Desvenlafaxine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	8.14e-05	0.000747	CcSEcCtD
Desvenlafaxine—Nausea—Indinavir—acquired immunodeficiency syndrome	8.12e-05	0.000746	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	8.11e-05	0.000744	CcSEcCtD
Desvenlafaxine—Headache—Efavirenz—acquired immunodeficiency syndrome	8.09e-05	0.000743	CcSEcCtD
Desvenlafaxine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	7.89e-05	0.000725	CcSEcCtD
Desvenlafaxine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	7.86e-05	0.000722	CcSEcCtD
Desvenlafaxine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	7.82e-05	0.000718	CcSEcCtD
Desvenlafaxine—Rash—Delavirdine—acquired immunodeficiency syndrome	7.79e-05	0.000716	CcSEcCtD
Desvenlafaxine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	7.79e-05	0.000715	CcSEcCtD
Desvenlafaxine—Headache—Delavirdine—acquired immunodeficiency syndrome	7.74e-05	0.000711	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	7.73e-05	0.00071	CcSEcCtD
Desvenlafaxine—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.67e-05	0.000705	CcSEcCtD
Desvenlafaxine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	7.56e-05	0.000694	CcSEcCtD
Desvenlafaxine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	7.53e-05	0.000692	CcSEcCtD
Desvenlafaxine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	7.53e-05	0.000691	CcSEcCtD
Desvenlafaxine—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.34e-05	0.000674	CcSEcCtD
Desvenlafaxine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.28e-05	0.000668	CcSEcCtD
Desvenlafaxine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.27e-05	0.000667	CcSEcCtD
Desvenlafaxine—Rash—Ritonavir—acquired immunodeficiency syndrome	7.21e-05	0.000662	CcSEcCtD
Desvenlafaxine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.2e-05	0.000661	CcSEcCtD
Desvenlafaxine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	7.18e-05	0.000659	CcSEcCtD
Desvenlafaxine—Headache—Ritonavir—acquired immunodeficiency syndrome	7.16e-05	0.000658	CcSEcCtD
Desvenlafaxine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	7e-05	0.000642	CcSEcCtD
Desvenlafaxine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	6.94e-05	0.000637	CcSEcCtD
Desvenlafaxine—Rash—Saquinavir—acquired immunodeficiency syndrome	6.94e-05	0.000637	CcSEcCtD
Desvenlafaxine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	6.93e-05	0.000636	CcSEcCtD
Desvenlafaxine—Headache—Saquinavir—acquired immunodeficiency syndrome	6.89e-05	0.000633	CcSEcCtD
Desvenlafaxine—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.79e-05	0.000624	CcSEcCtD
Desvenlafaxine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.67e-05	0.000613	CcSEcCtD
Desvenlafaxine—Rash—Lamivudine—acquired immunodeficiency syndrome	6.62e-05	0.000608	CcSEcCtD
Desvenlafaxine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.61e-05	0.000607	CcSEcCtD
Desvenlafaxine—Headache—Lamivudine—acquired immunodeficiency syndrome	6.58e-05	0.000604	CcSEcCtD
Desvenlafaxine—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.54e-05	0.0006	CcSEcCtD
Desvenlafaxine—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.23e-05	0.000573	CcSEcCtD
